Breastfeeding for six months may spur beneficial gut bacteria linked to lower childhood blood pressure
Nursing for at least six months may spur beneficial gut bacteria connected to better heart health years later. An observational ...
Tag: Heart
British Heart Foundation’s Centre of Research Excellence launches at The University of Manchester
The University of Manchester has launched the British Heart Foundation (BHF) Manchester Centre of Research Excellence following an award of £4 million ...
Do vitamin D supplements reduce acute respiratory infections?
Meta-analysis of 64,086 participants shows no significant overall reduction in acute respiratory infections with vitamin D supplementation, though children and ...
Potassium analysis with ion chromatography according to USP testing methods
In 2010 the United States Pharmacopeia (USP) began modernizing their monographs. As a part of this effort, test methods for ...
Study unlocks key differences in heart inflammation
A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 ...
Long-term grape consumption shown to improve muscle health in both men and women
A new study from Western New England University (WNE) has revealed that long-term grape consumption significantly impacts muscle health, with ...
Lifestyle and environmental factors play bigger role in health and premature death than genetics
A new study led by researchers from Oxford Population Health has shown that a range of environmental factors, including lifestyle ...
Study highlights risks of stopping anticoagulants in older patients
For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of ...
Obesity and cognition: Surprising study links higher BMI to better memory
New research challenges the idea that obesity harms cognition—suggesting that, in some cases, higher BMI may be linked to stronger ...
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
